What's new

Human medicines European public assessment report (EPAR): Vimpat, lacosamide, Date of authorisation: 29/08/2008, Revision: 55, Status: Authorised

Human medicines European public assessment report (EPAR): Vimpat, lacosamide, Date of authorisation: 29/08/2008, Revision: 55, Status: Authorised

May 8, 2025 - 12:06
 0
Human medicines European public assessment report (EPAR): Vimpat, lacosamide, Date of authorisation: 29/08/2008, Revision: 55, Status: Authorised
Human medicines European public assessment report (EPAR): Vimpat, lacosamide, Date of authorisation: 29/08/2008, Revision: 55, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Givlaari, givosiran, D...

Next Article

ThredUp partners with UK's Beyond retro to take British vintage to US

Related Posts

PRIME: priority medicines

PRIME: priority medicines

May 6, 2025  0

Human medicines European public assessment report (EPAR): Tecentriq, atezolizumab, Date of authorisation: 20/09/2017, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR...

May 8, 2025  0

Human medicines European public assessment report (EPAR): Twynsta, telmisartan,amlodipine, Date of authorisation: 07/10/2010, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 28, 2025  0